Neurofisiología de la hipersexualidad secundaria al tratamiento de enfermedad de Parkinson

Deissy Herrera-Covarrubias, Nafissa Ismail, Genaro A Coria-Avila

Resumen


La hipersexualidad puede ser un síntoma secundario al tratamiento de la enfermedad de Parkinson (EP) y forma parte de algunos desórdenes en el control de impulsos en una proporción que va del 20-50% de los pacientes. En esta revisión analizamos las evidencias neurobiológicas que explican el incremento de la hipersexualidad durante el tratamiento con L-DOPA o agonistas dopaminergicos. Se llevó a cabo una búsqueda de información con los términos “Parkinson”, “Hypersexuality”, “Dopamine”, “Noradrenaline”, “L-DOPA”, “Brain”, “Impulse Control Disorders”, “Neurobiology”, buscadas en las bases de datos de PubMed, sciELO y Science Direct. La EP se caracteriza por la pérdida progresiva de neuronas dopaminérgicas de la parte compacta de la sustancia nigra y que proyectan al estriado, produciendo un desbalance en la capacidad motora. Al igual que hace 50 años el tratamiento actual para la EP redunda en el uso de agentes que eleven la disponibilidad de dopamina y otras aminas como la noradrenalina. El tratamiento con L-DOPA o agonistas específicos incrementa los niveles de actividad de dichas aminas incluso en estructuras cerebrales no claramente afectadas por la EP, como las proyecciones tubero-infundibulares y mesolímbicas. El incremento de actividad dopaminérgica en áreas específicas como el núcleo accumbens y el área preóptica/hipotálamo anterior puede explicar la hipersexualidad observada con el incremento súbito en los niveles de motivación y excitación sexual en pacientes tratados para la EP.




Palabras clave


Hipersexualidad; parkinson; dopamina; noradrenalina; accumbens; área preóptica.

Texto completo:

PDF

Referencias


WHO. Neurological disorders Public health challenges. 2006 [cited 2015 01/05/2015]; Available from: http://www.who.int/mental_health/neurology/neurological_disorders_report_web.pdf?ua=1

Parkinson J. An essay on the shaking palsy. Whittingham & Rowland for Sherwood, Neely and Jones. London. 1817 88.

Carlsson A, Lindqvist M, Magnusson T, Waldeck B. On the presence of 3-hydroxytyramine in brain. Science 1958 127: 471.

Barbeau A. L-dopa therapy in Parkinson's disease: a critical review of nine years' experience. Can Med Assoc J 1969 101: 59-68.

Ehringer H, Hornykiewicz O. [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]. Klin Wochenschr 1960 38: 1236-9.

Barbeau A. Preliminary observations on abnormal catecholamine metabolism in basal ganglia diseases. Neurology 1960 10: 446-51.

Barbeau A, Murphy GF, Sourkes TL. Excretion of dopamine in diseases of basal ganglia. Science 1961 133: 1706-7.

Miyasaki JM, Martin W, Suchowersky O, Weiner WJ, Lang AE. Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2002 58: 11-7.

Ives NJ, Stowe RL, Marro J, Counsell C, Macleod A, Clarke CE, Gray R, Wheatley K. Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients. BMJ 2004 329: 593.

Hadjiconstantinou M, Neff NH. Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson's disease. CNS Neurosci Ther 2008 14: 340-51.

Reyes D, Kurako K, Galvez-Jimenez N. Rasagiline induced hypersexuality in Parkinson's disease. J Clin Neurosci 2014 21: 507-8.

Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 1998 28: 309-69.

Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol 1998 80: 1-27.

Vazquez-Saanchez F, Rodriguez-Martinez E, Ares-Luque A. [Urinary disorders, sexual dysfunction and hypersexuality in Parkinson's disease]. Rev Neurol 2010 50 Suppl 2: S27-31.

Chunghtai B, Sciullo D, Hhan S, Rehman H, Mohan E, Rehman J. Etiology, diagnosis and management of hypersexuality: a review. The Internet Journal of Urology 2009 6.

Hsu C. Parkinson's Medication Turned Respected Family Man into "Gay Sex and Gambling Addict". 2012 [cited 2015 28/04/2015]; Available from: http://www.medicaldaily.com/parkinsons-medication-turned-respected-family-man-gay-sex-and-gambling-addict-243707.

Kow LM, Pfaff DW. Transmitter and peptide actions on hypothalamic neurons in vitro: implications for lordosis. Brain Res Bull 1988 20: 857-61.

Pfaff DW. Drive: Neurobiological and molecular mechanisms of sexual motivation. MIT press. 1999.

Pfaus JG. Pathways of sexual desire. J Sex Med 2009 6: 1506-33.

Berkowicz DA, Trombley PQ. Dopaminergic modulation at the olfactory nerve synapse. Brain Res 2000 855: 90-9.

Brunig I, Sommer M, Hatt H, Bormann J. Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci USA 1999 96: 2456-60.

Hull EM, Lorrain DS, Du J, Matuszewich L, Lumley LA, Putnam SK, Moses J. Hormone-neurotransmitter interactions in the control of sexual behavior. Behav Brain Res 1999 105: 105-16.

Fluxe K, Hokfelt T, Johansson O, Jonsson G, Lidbrink P, Ljungdahl A. The origin of the dopamine nerve terminals in limbic and frontal cortex. Evidence for meso-cortico dopamine neurons. Brain Res 1974 82: 349-55.

Lindvall O, Bjorklund A, Moore RY, Stenevi U. Mesencephalic dopamine neurons projecting to neocortex. Brain Res 1974 81: 325-31.

Yim CY, Mogenson GJ. Response of nucleus accumbens neurons to amygdala stimulation and its modification by dopamine. Brain Res 1982 239: 401-15.

Lindvall O. Mesencephalic dopaminergic afferents to the lateral septal nucleus of the rat. Brain Res 1975 87: 89-95.

Roth RH, Elsworth JD. Biochemical pharmacology of midbrain dopamine neurons. En: Bloom FE and DJ Kupfer, Psychopharmacology: The fourth generation of progress. Raven 1995 227-244.

Moore KE, Looklingand KJ. Dopaminergic neuronal systems in the hypothalamus. En: Bloom FE and DJ Kupfer, Psychopharmacology: The fourth generation of progress. Raven 1995 245-256.

Hoshina Y, Takeo T, Nakano K, Sato T, Sakuma Y. Axon-sparing lesion of the preoptic area enhances receptivity and diminishes proceptivity among components of female rat sexual behavior. Behav Brain Res 1994 61: 197-204.

Paredes RG. Medial preoptic area/anterior hypothalamus and sexual motivation. Scand J Psychol 2003 44: 203-12.

Liu YC, Sachs BD, Salamone JD. Sexual behavior in male rats after radiofrequency or dopamine-depleting lesions in nucleus accumbens. Pharmacol Biochem Behav 1998 60: 585-92.

Guarraci FA, Megroz AB, Clark AS. Effects of ibotenic acid lesions of the nucleus accumbens on paced mating behavior in the female rat. Behav Neurosci 2002 116: 568-76.

Hull EM, Du J, Lorrain DS, Matuszewich L. Testosterone, preoptic dopamine, and copulation in male rats. Brain Res Bull 1997 44: 327-33.

Malmnas CO. Dopaminergic reversal of the decline after castration of rat copulatory behaviour. J Endocrinol 1977 73: 187-8.

Malmnas CO. The significance of dopamine, versus other catecholamines, for L-dopa induced facilitation of sexual behavior in the castrated male rat. Pharmacol Biochem Behav 1976 4: 521-6.

Hyyppa M, Rinne UK, Sonninen V. The activating effect of L-dopa treatment on sexual functions and its experimental background. Acta Neurol Scand 1970 46: Suppl 43:223+.

Heaton JP, Varrin SJ, Morales A. The characterization of a bio-assay of erectile function in a rat model. J Urol 1991 145: 1099-102.

Lal S, Ackman D, Thavundayil JX, Kiely ME, Etienne P. Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects. Prog Neuropsychopharmacol Biol Psychiatry 1984 8: 695-9.

McIntosh TK, Barfield RJ. Brain monoaminergic control of male reproductive behavior. II. Dopamine and the post-ejaculatory refractory period. Behav Brain Res 1984 12: 267-73.

Pfaus JG, Phillips AG. Role of dopamine in anticipatory and consummatory aspects of sexual behavior in the male rat. Behav Neurosci 1991 105: 727-43.

Becker JB. Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release. Synapse 1990 5: 157-64.

Sato S, Braham CS, Putnam SK, Hull EM. Neuronal nitric oxide synthase and gonadal steroid interaction in the MPOA of male rats: co-localization and testosterone-induced restoration of copulation and nNOS-immunoreactivity. Brain Res 2005 1043: 205-13.

Everitt BJ, Cador M, Robbins TW. Interactions between the amygdala and ventral striatum in stimulus-reward associations: studies using a second-order schedule of sexual reinforcement. Neuroscience 1989 30: 63-75.

Blackburn JR, Pfaus JG, Phillips AG. Dopamine functions in appetitive and defensive behaviours. Prog Neurobiol 1992 39: 247-79.

• Meisel RL, Sachs BD. The physiology of male reproduction. En: Knobil E and JD Neil, The physiology of reproduction. Raven Press 1994 3-105.

Fiorino DF, Coury A, Phillips AG. Dynamic changes in nucleus accumbens dopamine efflux during the Coolidge effect in male rats. J Neurosci 1997 17: 4849-55.

Aragona BJ, Liu Y, Curtis JT, Stephan FK, Wang Z. A critical role for nucleus accumbens dopamine in partner-preference formation in male prairie voles. J Neurosci 2003 23: 3483-90.

Gingrich B, Liu Y, Cascio C, Wang Z, Insel TR. Dopamine D2 receptors in the nucleus accumbens are important for social attachment in female prairie voles (Microtus ochrogaster). Behav Neurosci 2000 114: 173-83.

Williams JR, Catania KC, Carter CS. Development of partner preferences in female prairie voles (Microtus ochrogaster): the role of social and sexual experience. Horm Behav 1992 26: 339-49.

Triana-Del Rio R, Tecamachaltzi-Silvaran MB, Diaz-Estrada VX, Herrera-Covarrubias D, Corona-Morales AA, Pfaus JG, Coria-Avila GA. Conditioned same-sex partner preference in male rats is facilitated by oxytocin and dopamine: effect on sexually dimorphic brain nuclei. Behav Brain Res 2015 283: 69-77.

Cibrian-Llanderal T, Rosas-Aguilar V, Triana-Del Rio R, Perez CA, Manzo J, Garcia LI, Coria-Avila GA. Enhaced D2-type receptor activity facilitates the development of conditioned same-sex partner preference in male rats. Pharmacol Biochem Behav 2012 102: 177-83.

Triana-Del Rio R, Montero-Dominguez F, Cibrian-Llanderal T, Tecamachaltzi-Silvaran MB, Garcia LI, Manzo J, Hernandez ME, Coria-Avila GA. Same-sex cohabitation under the effects of quinpirole induces a conditioned socio-sexual partner preference in males, but not in female rats. Pharmacol Biochem Behav 2011 99: 604-13.

Manzo J, Carrillo P, Pérez-Pouchoulen M. lenguaje químico del sistema nervioso. En: Coria¬Avila GA, Neurofisiología de la conducta. Universidad Veracruzana 2012 44-60.

Moore RY, Bloom FE. Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci 1979 2: 113-68.

Green JD, Clemente CD, De Groot J. Rhinencephalic lesions and behavior in cats: an analysis of the Kluver-Bucy syndrome with particular reference to normal and abnormal sexual behavior. J Comp Neurol 1957 108: 505-45.

Clark JT, Smith ER. Clonidine suppresses copulatory behavior and erectile reflexes in male rats: lack of effect of naloxone pretreatment. Neuroendocrinology 1990 51: 357-64.

Rodriguez-Manzo G, Fernandez-Guasti A. Reversal of sexual exhaustion by serotonergic and noradrenergic agents. Behav Brain Res 1994 62: 127-34.

Allard J, Giuliano F. Central nervous system agents in the treatment of erectile dysfunction: how do they work? Curr Urol Rep 2001 2: 488-94.

Smith ER, Maurice J, Richardson R, Walter T, Davidson JM. Effects of four beta-adrenergic receptor antagonists on male rat sexual behavior. Pharmacol Biochem Behav 1990 36: 713-7.

Ramirez OA, Carrer HF. Effect of estrogen and progesterone priming on the uptake and release of serotonin and noradrenaline from the ventromedial hypothalamus. Acta Physiol Lat Am 1982 32: 313-9. 61.

Fernandez-Guasti A, Larsson K, Beyer C. Potentiative action of alpha- and beta-adrenergic receptor stimulation in inducing lordosis behavior. Pharmacol Biochem Behav 1985 22: 613-7.




DOI: https://doi.org/10.25009/eb.v6i13.2582

Enlaces refback

  • No hay ningún enlace refback.


 

eNeurobiología es una publicación cuatrimestral editada por el Instituto de Investigaciones Cerebrales de la Universidad Veracruzana. Estamos ubicados en Av. Dr. Luis Castelazo Ayala, s/n, colonia Industrial Ánimas, C.P. 91190, Xalapa-Enríquez, Veracruz, México. Teléfono: 8418900 ext. 13062, www.iice.uv.mx; eneurobiologia@uv.mx. Reserva de Derechos al Uso Exclusivo 04-2023-061314100600-102, otorgada por el Instituto Nacional de Derechos de Autor. ISSN: 2007-3054. Esta obra está bajo una Licencia Creative Commons Attribution 4.0 International.